Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Ramona Kohlrausch"'
Autor:
Maria Eduarda Krützmann, Ranieri Reichel Martini, Fernanda de Souza Guterres, Ramona Kohlrausch, Sandrine Comparsi Wagner, Vanessa Suñe Mattevi, Mayde Seadi Torriani, Laura Maria Fogliatto, Rafael Linden, Marina Venzon Antunes
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 222
Chronic Myeloid Leukemia (CML) is a hematologic neoplasia, characterized as a proliferative disease of the hematopoietic system. Imatinib mesylate (IM), a selective tyrosine kinase inhibitor, is considered a first-line therapy for CML, indicated for
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e8a54bd54472a8d9adfb919f0fcdb2f
https://pubmed.ncbi.nlm.nih.gov/36279845
https://pubmed.ncbi.nlm.nih.gov/36279845
Autor:
Eliana Carniel, Karen Adams dos Santos, Lucas de Andrade de Lima, Ramona Kohlrausch, Rafael Linden, Marina Venzon Antunes
Publikováno v:
Journal of Pharmaceutical and Biomedical Analysis. 210:114591
The use of alternative blood sampling strategies in clozapine (CLZ) therapeutic drug monitoring (TDM) aims to facilitate collection and improve drug therapy and adherence. This study aimed to develop and validate two methods for the determination CLZ
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4a4e33598010be11a764bf60f7b47f7d
https://doi.org/10.1016/j.jpba.2022.114591
https://doi.org/10.1016/j.jpba.2022.114591